Society of Hematologic Oncology (SOHO)
@SocietyofHemOnc
Followers
7K
Following
1K
Media
382
Statuses
892
The only worldwide society dedicated to hematologic malignancies. Join SOHO FREE➡️ https://t.co/6ft3NJpoB2 Register for SBBC: https://t.co/MbgVh2ZilG
Houston, TX
Joined July 2015
Outside of clinical trials, available data with the second-generation TKI dasatinib show very strong results, says @NicholasShortMD in this interview with @DrHKantarjian at #SOHO2025. https://t.co/BTlpFv7kMC
0
0
2
What can leukemia take from myeloma’s playbook? @Doctor_E_Stein and @szusmani discuss menin inhibitors and how combination strategies can advance leukemia care. https://t.co/CNJyRUoyGv
0
0
1
"Aequanimitas,” meaning coolness and presence of mind under all circumstances, was Sir William Osler’s mantra. Our SI Associate Editor Dr. Amy DeZern writes about how she carries the mantra with her throughout the day in this editorial. @JohnsHopkins
https://t.co/Q9SEJmPOnf
sohoinsider.com
By: Amy DeZern, MD, MHS Thanks to the many happy choices I have made over the years, my personal and professional lives are full and busy in 2025. However, that doesn’t mean that day-to-day life is...
0
0
7
Early-phase CLL trial shows bexobrutideg well tolerated https://t.co/YDYlzN85hQ
sohoinsider.com
Updated results from an early-phase chronic lymphocytic leukemia trial of heavily pretreated patients showed that once-daily dosing of the Bruton’s tyrosine kinase (BTK) degrader bexobrutideg was...
0
0
2
BTK ‘degrader’ bexdeg shines in Waldenström macroglobulinemia https://t.co/nqSo56fQuV
sohoinsider.com
By: Emily Hayes Attendees of SOHO 2025 got a closer look at positive early safety and efficacy data for the novel Bruton’s tyrosine kinase (BTK)-targeted drug bexobrutideg in heavily pretreated...
0
0
5
Early-phase CLL trial shows bexobrutideg well tolerated https://t.co/YDYlzN85hQ
sohoinsider.com
Updated results from an early-phase chronic lymphocytic leukemia trial of heavily pretreated patients showed that once-daily dosing of the Bruton’s tyrosine kinase (BTK) degrader bexobrutideg was...
0
0
0
Radiation from medical imaging increases risk of blood cancers in children @nejmunofficial #MedTwitter
https://t.co/IpLaZIryTp
0
0
2
SOHO 2026 exhibit & sponsorship opportunities are open! Connect with 3,000+ HemOnc professionals, maximize visibility, and build lasting connections. Space is limited and first-come, first-served—secure your spot today at https://t.co/FasYd3pwre
#SOHO2026
0
1
8
Dr. Kantarjian interviews Dr. Graff on MorningSun trial at #SOHO2025 #MZL #MedTwitter
https://t.co/qbmN5xoa39
0
1
7
The next breakthrough starts here 🔨. Join us on November 20 for a one-day, virtual meeting, featuring leaders in #hemonc. Save your seat by registering today at https://t.co/wlSCXZtel5. Free for members; $50 for non-SOHO members. @DrHKantarjian @SagarLonialMD @Ramikomrokji
0
7
19
Late post but always an honor representing my institution! And of course heme/onc over anything, anyday 🩸 #soho2025
5
2
203
Free patient resource aims to guide those with difficult diagnoses @DrHKantarjian @MDAndersonNews
https://t.co/XXPkUu8LRx
0
0
1
New @theNCI director Dr. Anthony Letai whose research led to the BCL2 inhibitor venetoclax for #CLL and #AML sworn in today at at the nation’s top cancer institute. https://t.co/Srt6a2uCYg
0
2
4
I am very grateful for the Young Investigator Award and for the opportunity to present our poster at SOHO this year! It was an inspiring experience, and I’m truly thankful to my mentors. #SOHO2025
8
7
284
The 3rd SOHO MENA is underway in the ❤️ of Beirut, Watch @M2medLb for more updates on the meeting. #SOHOMENA25.
0
3
14
Join John Mascarenhas, MD, @IcahnMountSinai, and colleagues for this @SocietyofHemOnc virtual meeting on blood cancers.
The next breakthrough starts here 🔨. Join us on November 20 for a one-day, virtual meeting, featuring leaders in #hemonc. Save your seat by registering today at https://t.co/wlSCXZtel5. Free for members; $50 for non-SOHO members. @DrHKantarjian @SagarLonialMD @Ramikomrokji
0
1
1
🎉 Celebrating excellence at the 2025 @OSUCCC_James Physician Recognition Celebration! 10 Heme physicians were honored for outstanding leadership, teamwork, research, and patient care in early September. 👏❤️ @kmaddmd @sumithira_vasu @tvoorheesmd @beatalleukemia @mmosuccc
0
6
19
Did you know that SOHO launched a pilot program focused in R/R CLL/SLL for SOHO young investigators? Read about the program & the young investigators participating here: https://t.co/Ew97IOjbLq
0
1
5